|
Zinc in PDB 5vz1: Crystal Structure of the Apo Antibody Fragment (Fab) Raised Against C- Terminal Domain of Ebola Nucleoprotein (Ebov, Tafv, Bdbv Strains)Protein crystallography data
The structure of Crystal Structure of the Apo Antibody Fragment (Fab) Raised Against C- Terminal Domain of Ebola Nucleoprotein (Ebov, Tafv, Bdbv Strains), PDB code: 5vz1
was solved by
M.J.Radwanska,
U.Derewenda,
A.Kossiakoff,
Z.S.Derewenda,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of the Apo Antibody Fragment (Fab) Raised Against C- Terminal Domain of Ebola Nucleoprotein (Ebov, Tafv, Bdbv Strains)
(pdb code 5vz1). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the Crystal Structure of the Apo Antibody Fragment (Fab) Raised Against C- Terminal Domain of Ebola Nucleoprotein (Ebov, Tafv, Bdbv Strains), PDB code: 5vz1: Jump to Zinc binding site number: 1; 2; Zinc binding site 1 out of 2 in 5vz1Go back to Zinc Binding Sites List in 5vz1
Zinc binding site 1 out
of 2 in the Crystal Structure of the Apo Antibody Fragment (Fab) Raised Against C- Terminal Domain of Ebola Nucleoprotein (Ebov, Tafv, Bdbv Strains)
Mono view Stereo pair view
Zinc binding site 2 out of 2 in 5vz1Go back to Zinc Binding Sites List in 5vz1
Zinc binding site 2 out
of 2 in the Crystal Structure of the Apo Antibody Fragment (Fab) Raised Against C- Terminal Domain of Ebola Nucleoprotein (Ebov, Tafv, Bdbv Strains)
Mono view Stereo pair view
Reference:
M.J.Radwanska,
U.Derewenda,
A.Kossiakoff,
Z.S.Derewenda.
Crystal Structure of the Apo Antibody Fragment (Fab) Raised Against C-Terminal Domain of Ebola Nucleoprotein (Ebov, Tafv, Bdbv Strains) To Be Published.
Page generated: Wed Dec 16 11:13:33 2020
|
Last articlesZn in 8WB0Zn in 8WAX Zn in 8WAU Zn in 8WAZ Zn in 8WAY Zn in 8WAV Zn in 8WAW Zn in 8WAT Zn in 8W7M Zn in 8WD3 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |